MBNL3 was revealed to act as a target of miR-302e to facilitate cell proliferation, invasion, and angiogenesis of gastric adenocarcinoma through the AKT/VEGFA pathway. The gene discussed is AKT1; the disease is gastric adenocarcinoma.